02/28
Headlines

Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.

Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Mark DeFrance03 mins

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is up over 16% today on news of the company’s initiation of phase-II trials for its lead drug candidate KRN23, which is a monoclonal antibody for X-linked Hypophosphatemia (XLH). Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) stock performance was 14.30% in last session and finished the day at $48.67. Traded volume was 435,645.00million shares…

Read More

Stocks With New Highs: The Valspar Corporation (NYSE:VAL), Energen Corporation (NYSE:EGN), Enerplus (NYSE:ERF), Tronox Ltd (NYSE:TROX), Comstock Resources Inc (NYSE:CRK)

Mark DeFrance03 mins

The Valspar Corporation (NYSE:VAL) has received a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, AnalystRatings.Net reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have given a buy rating to the company. The Valspar Corporation (NYSE:VAL) stock…

Read More

Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Mark DeFrance03 mins

Drugmaker Vivus Inc. (NASDAQ:VVUS) said Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of company’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -0.19% in last session and…

Read More

Solar Stocks In News: Canadian Solar Inc. (NASDAQ:CSIQ), Trina Solar Limited (ADR) (NYSE:TSL), SolarCity Corp (NASDAQ:SCTY), Hanwha Solarone Co Ltd (NASDAQ:HSOL), LDK Solar Co., Ltd (ADR) (OTCMKTS:LDKSY)

Mark DeFrance03 mins

Canadian Solar Inc. (NASDAQ:CSIQ) will build a plant for photovoltaic cells in China in partnership with GCL-Poly Energy Holdings Ltd. (3800), the country’s largest polysilicon and wafer producer. Canadian Solar Inc. (NASDAQ:CSIQ) stock performance was 3.42% in last session and finished the day at $25.97. Traded volume was 3.33million shares in the last session and…

Read More

Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Questcor Pharmaceuticals(NASDAQ:QCOR), Seattle Genetics (NASDAQ:SGEN), Repligen Corporation (NASDAQ:RGEN), bluebird bio (NASDAQ:BLUE)

Mark DeFrance03 mins

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) major shareholder Qvt Associates Gp Llc sold 128,649 shares of the company’s stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $7.66, for a total transaction of $985,451.34. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -6.32% in last session and finished the day…

Read More

Volatile Movements: JD.Com (NASDAQ:JD), RadioShack Corporation (NYSE:RSH), Santander Consumer USA (NYSE:SC), Provectus Biopharmaceuticals (NYSEMKT:PVCT), Quicksilver Resources (NYSE:KWK)

Mark DeFrance03 mins

Retail site JD.com Inc (ADR) (NASDAQ:JD) attracted $1.78 billion in a May offer, and social media platform Weibo Corp completed a $285.6 million debut in April as Alibaba prepares what may be the biggest IPO ever. JD.Com Inc (ADR) (NASDAQ:JD) stock performance was -6.31% in last session and finished the day at $27.17. Traded volume…

Read More